Carlton A. Evans is
-Professor of Global Health leading the IFHAD: Innovation For Health And Development group in the Section of Adult Infectious Disease, Department of Infectious Disease at Imperial College London, UK;
-Honorary Consultant (Attending) Physician specialising in infectious disease and general medicine (special interests tuberculosis and global health with a Diploma in Tropical Medicine and Hygiene) for patients at Imperial College Healthcare NHS Trust, UK;
-Professor of Research in the Laboratory of Research and Development at Universidad Peruana Cayetano Heredia, Peru.
-Head of Innovation For Health and Development at the Non-governmental organisation (NGO, charity) Asociacion Benefica PRISMA, Peru
-Associate faculty in the Department of International Health, Johns Hopkins School of Public Health, USA.
IFHAD: Innovation For Health And Development (www.ifhad.org) is a multi-disciplinary research team founded and led by Carlton Evans that integrates the above institutions with activities especially in Peru.
Research is focused on innovative strategies for improving health and development, especially for vulnerable people globally. This includes developing and evaluating novel, practical strategies for integrating development and health interventions to reduce poverty and prevent associated tuberculosis in resource-constrained settings. See publications: https://goo.gl/CUYV9G and www.ifhad.org/publications/ and further information: https://orcid.org/0000-0002-6873-5447
Setting. Most of this research takes place in Peru, with collaborative research sites in several other countries.
Impacts include strengthening global policy and practice in tuberculosis:
-integration with psycho-socioeconomic interventions.
Empowerment, equitable partnership and capacity building are core priorities in all our work. Our research team includes interns, PhD and Masters students, health-carers, scientists and biologists in an international training network.
Mentorship includes multiple current and completed PhD, Masters and internship fellowships.
Collaborations in addition to the above list of institutions include:
-The Peruvian Ministry of Health;
-University of Liverpool, UK;
Tulane University, USA;
-The London School of Hygiene and Tropical Medicine, UK;
and is coordinated with Imperial College London, UK.
Funding is gratefully acknowledged from multiple sponsors including:
-The Wellcome Trust;
-The Medical Research Council, UK;
The Joint Global Health Trials consortium (MRC, DFID, & Wellcome Trust);
-The Department of Health and Social Services of the UK government;
Imperial College National Institutes of Health Research Biomedical Research Centre;
-The Foundation for Innovative New Diagnostics (FIND);
-The Sir Halley Stewart Trust;
-The World Health Organization;
-The World Bank;
-The STOP TB partnership’s TB REACH initiative funded by the Government of Canada and;
-The Bill & Melinda Gates Foundation; and
-The charity fund IFHAD: Innovation For Health And Development.
Consultancies have included the World Bank, the London School of Hygiene and Tropical Medicine, Asociacion Benefica PRISMA, Universidad Peruana Cayetano Heredia, Médecins Sans Frontières and the World Health Organisation.
This work led to the honour of an MBE in the Queen's New Year Honours List 2021.
Please send an email enquiry for further information or if you are interested in working with or supporting IFHAD.
Allen J, Evans CA, Datta S, 2022, Probiotics for preventing or treating COVID-19; a systematic review of research evidence and meta-analyses of efficacy for preventing death, severe disease, or disease progression, Wellcome Open Research, Vol:7, Pages:292-292
et al., 2022, A protocol for a systematic review and meta-analysis of strategies to quantify or eliminate catastrophic costs due to tuberculosis, Wellcome Open Research, Vol:7, Pages:92-92
et al., 2022, Interventions aiming to eliminate catastrophic costs due to tuberculosis: a protocol for a systematic review and meta-analysis., Wellcome Open Research, Vol:7, ISSN:2398-502X
et al., 2022, Interventions aiming to eliminate catastrophic costs due to tuberculosis: a protocol for a systematic review and meta-analysis., Wellcome Open Res, Vol:7, ISSN:2398-502X
et al., 2021, REASONS FOR CONSENTING TO PARTICIPATE IN COMMUNITY RESEARCH AIMED TO PREVENT TUBERCULOSIS, AMER SOC TROP MED & HYGIENE, Pages:401-402, ISSN:0002-9637